ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR)

CUSIP: N71542109

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Ordinary Shares, nominal value Euro 0.04 per share
Shares outstanding
105,371,575
Total 13F shares
40,456,202
Share change
-862,261
Total reported value
$82,379,793
Put/Call ratio
0%
Price per share
$2.04
Number of holders
61
Value change
-$1,567,785
Number of buys
20
Number of sells
27

Quarterly Holders Quick Answers

What is CUSIP N71542109?
CUSIP N71542109 identifies PRQR - ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) as of Q2 2025

As of 30 Jun 2025, ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) was held by 61 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 40,456,202 shares. The largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., Privium Fund Management B.V., Affinity Asset Advisors, LLC, MORGAN STANLEY, Sio Capital Management, LLC, Aberdeen Group plc, Kynam Capital Management, LP, DAFNA Capital Management LLC, Siren, L.L.C., and Woodline Partners LP. This page lists 61 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.